These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 1672878

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of the efficacy and tolerability of topical levocabastine and sodium cromoglycate in the treatment of seasonal allergic rhinoconjunctivitis in children.
    Vermeulen J, Mercer M.
    Pediatr Allergy Immunol; 1994 Nov; 5(4):209-13. PubMed ID: 7894627
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Double-blind comparison of levocabastine eye drops with sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis.
    Azevedo M, Castel-Branco MG, Oliveira JF, Ramos E, Delgado L, Almeida J.
    Clin Exp Allergy; 1991 Nov; 21(6):689-94. PubMed ID: 1685691
    [Abstract] [Full Text] [Related]

  • 8. Efficacy, cost-effectiveness, and tolerability of mometasone furoate, levocabastine, and disodium cromoglycate nasal sprays in the treatment of seasonal allergic rhinitis.
    Lange B, Lukat KF, Rettig K, Holtappels G, Bachert C.
    Ann Allergy Asthma Immunol; 2005 Sep; 95(3):272-82. PubMed ID: 16200819
    [Abstract] [Full Text] [Related]

  • 9. Levocabastine: an effective topical treatment of allergic rhinoconjunctivitis.
    Janssens MM, Vanden Bussche G.
    Clin Exp Allergy; 1991 May; 21 Suppl 2():29-36. PubMed ID: 1680536
    [Abstract] [Full Text] [Related]

  • 10. Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis.
    Noble S, McTavish D.
    Drugs; 1995 Dec; 50(6):1032-49. PubMed ID: 8612470
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A comparison of topical levocabastine and sodium cromoglycate in the treatment of pollen-provoked allergic conjunctivitis.
    Frostad AB, Olsen AK.
    Clin Exp Allergy; 1993 May; 23(5):406-9. PubMed ID: 8101467
    [Abstract] [Full Text] [Related]

  • 15. Intranasal levocabastine provides fast and effective protection from nasal allergen challenge.
    Bachert C, Wagenmann M, Vossen-Holzenkamp S.
    Rhinology; 1996 Sep; 34(3):140-3. PubMed ID: 8938880
    [Abstract] [Full Text] [Related]

  • 16. Comparison of levocabastine, a new selective H1-receptor antagonist, and disodium cromoglycate, in a nasal provocation test with allergen.
    Kolly M, Pécoud A.
    Br J Clin Pharmacol; 1986 Oct; 22(4):389-94. PubMed ID: 2876723
    [Abstract] [Full Text] [Related]

  • 17. Levocabastine. A review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis.
    Dechant KL, Goa KL.
    Drugs; 1991 Feb; 41(2):202-24. PubMed ID: 1709851
    [Abstract] [Full Text] [Related]

  • 18. Effects of topical budesonide and levocabastine on nasal symptoms and plasma exudation responses in seasonal allergic rhinitis.
    Svensson C, Andersson M, Greiff L, Blychert LO, Persson CG.
    Allergy; 1998 Apr; 53(4):367-74. PubMed ID: 9574878
    [Abstract] [Full Text] [Related]

  • 19. Topical levocabastine compared with oral loratadine for the treatment of seasonal allergic rhinoconjunctivitis. Swedish GP Allergy Team.
    Allergy; 1994 Sep; 49(8):611-5. PubMed ID: 7653738
    [Abstract] [Full Text] [Related]

  • 20. Comparative efficacy and safety of azelastine and levocabastine nasal sprays in patients with seasonal allergic rhinitis.
    Falser N, Wober W, Rahlfs VW, Baehre M.
    Arzneimittelforschung; 2001 Sep; 51(5):387-93. PubMed ID: 11413739
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.